Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Sulku (Gävle, Sweden). Refined ABCD assessment tool in COPD – results from the TIE-study. 928

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 The REVEAL registry: a tool for the evaluation of PAH disease management Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Different methods to classify COPD patients into the ABCD severity groups – Preliminary results of the LQ-DMP project Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Blood biomarker algorithms to guide COPD assessment and risk stratification Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 An evidence based strategy for case-finding of COPD. Results of the Dutch DIMCA-Program Source: Eur Respir J 2006; 28: Suppl. 50, 366s Year: 2006 Distribution of a COPD population based on the GOLD assessment framework Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Combined COPD assessment using the new GOLD guidelines Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Design and assessment of an automated prediction model for 30-day re-hospitalization after a COPD exacerbation using genetic algorithms Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Development and validation of a simple tool for clinical assessment of patients treated with home NIV: The S3-NIV questionnaire Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017 Developing a claims’-based algorithm to identify US patients with COPD Source: International Congress 2019 – More and more COPD Year: 2019 Measurement of COPD severity: development and validation of a survey-based instrument Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 A simple algorithm for the identification of clinical COPD phenotypes Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017 Year: 2017 Clinical prediction guides in COPD, a real life evaluation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Measurement of COPD severity: further validation of a survey-based instrument Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 COPD: algorithms and clinical management Source: Eur Respir J, 50 (5) 1701733; 10.1183/13993003.01733-2017 Year: 2017